title: B cells in health and disease.
abstract: B cells play a key role in regulating the immune system by producing antibodies, acting as antigen-presenting cells, providing support to other mononuclear cells, and contributing directly to Inflammatory pathways. Accumulating evidence points to disruption of these tightly regulated processes in the pathogenesis of autoimmune disorders. Although the exact mechanisms involved remain to be elucidated, a fundamental feature of many autoimmune disorders is a loss of B-cell tolerance and the inappropriate production of autoantibodies. Dysfunctional immune responses resulting from genetic mutations that cause intrinsic B-cell abnormalities and induction of autoimmunity in the T-cell compartment by B cells that have broken tolerance may also contribute to these disorders. These findings provide the rationale for B-cell depletion as a potential therapeutic strategy in autoimmune disorders and other disease states characterized by inappropriate immune responses. Preliminary results with the CD20-targeted monoclonal antibody rituximab indicate that rituximab can improve symptoms in a number of autoimmune and neurologic disorders (including rheumatoid arthritis, systemic lupus erythematosus, and paraneoplastic neurologic syndromes). Additional studies are warranted to further characterize the role of B cells in autoimmune diseases and the therapeutic utility of B-cell depletion.
authors.affiliation: Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, 409 LHRB, Birmingham, AL 35294-0007, USA. rcarter@uab.edu
authors.forename: Robert H
authors.initials: RH
authors.lastname: Carter
mesh_terms: D001327:Autoimmune Diseases / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D001402:B-Lymphocytes / Q000502:physiology*; D006304:Health Status; D006801:Humans; D007109:Immunity / Q000502:physiology*; D007155:Immunologic Factors / Q000627:therapeutic use
chemical_list: D007155:Immunologic Factors